Treatment of Stage I-II A Non-Bulky Hodgkin’s Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Konference: 2012 54th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 623. Lymphoma - Chemotherapy, excluding Pre-Clinical Models

Číslo abstraktu: 0548

Autoři: Annette E. Hay, MBChB; MD Beate Klimm; Bingshu E. Chen, PhD; Helen Goergen; MD Lois E. Shepherd; MD Michael Fuchs; MD Mary Gospodarowicz; MD Peter Borchmann, PhD; MD Joseph M. Connors; MUDr. Jana Marková; MD Michael Crump, FRCPC; MD Andreas Lohri; MD Jane N. Winter, Northwestern University Feinberg School of Medicine; Bernd Dörken (Doerken); MD Robert G. Pearcey; MD Volker Diehl; MD Sandra J. Horning; MD Hans Theodor Eich; Prof. MD Andreas Engert; MD Ralph M. Meyer

Datum přednesení příspěvku: 10. 12. 2012